Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosup pression in an individual for use intreating a …
reduction of the level of systemic immunosup pression in an individual for use intreating a …
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
7,563,869 B2 7/2009 Honjo et al. 8,008,449 B2 8/2011 Korman et al. 8,552,154 B2 10/2013
Freeman et al. 8,629,098 B2 1/2014 Fahmy et al. 8,709,416 B2 4/2014 Langermann et al …
Freeman et al. 8,629,098 B2 1/2014 Fahmy et al. 8,709,416 B2 4/2014 Langermann et al …
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2019 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosup pression in an individual for use in treating a …
reduction of the level of systemic immunosup pression in an individual for use in treating a …
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
of systemic immunosuppression in an individual for use in treating a disease, disorder …